Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation (Tables)

v3.24.1.1.u2
Stock-Based Compensation (Tables)
 12 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity
The following table summarizes stock option activity:
Number of Shares Weighted-Average Exercise Price
(per share)		 Weighted-Average Remaining
Contractual
Life
(in years)		 Aggregate Intrinsic Value
(in thousands)
Options outstanding as of March 31, 2023
 6,950,436  $ 12.73  6.12 $ 45,689 
Granted 602,491  12.66 
Exercised (1,223,630) 3.24 
Forfeited / Expired (531,428) 27.42 
Options outstanding as of March 31, 2024
 5,797,869  $ 13.26  5.39 $ 2,423 
Exercisable as of March 31, 2024
 4,779,833  $ 11.64  4.70 $ 2,423 
Schedule of RSU, PSU and RSA Activity
The following table summarizes RSU, PSU, and RSA activity:
Number of Shares Weighted-Average Grant Date Fair Value
Unvested restricted shares outstanding as of March 31, 2023
 1,670,589  $ 24.96 
Granted 4,565,093  9.92 
Vested (1,723,149) 15.93 
Forfeited (592,691) 14.53 
Unvested restricted shares outstanding as of March 31, 2024
 3,919,842  $ 12.44 
Schedule of Market-based Assumptions The assumptions utilized in this model during fiscal years 2024, 2023, and 2022 are presented below.
  Year ended March 31,
  2024 2023 2022
Risk-free interest rate
3.82% to 4.29%
2.71% to 4.38%
0.63% to 1.77%
Expected life of the options (years)
4.70 to 4.72
5.27 to 5.33
4.82 to 5.27
Expected volatility
88% to 88%
72% to 80%
72% to 72%
Expected dividend yield —% —% —%
Schedule of Intrinsic Value of Stock Option
Total fair value of options vested and total intrinsic value of options exercised was as follows for the fiscal years presented:
  Year ended March 31,
  2024 2023 2022
Total fair value of options vested $ 12,334  $ 15,375  $ 11,495 
Total intrinsic value of options exercised $ 6,441  $ 16,909  $ 68,163